Alcon

Alcon Debt/Market Cap

The Debt to Market Capitalization Ratio of Alcon (ALC.SW) as of Sep 26, 2026 is 13.81 %. In the previous year, Debt to Market Capitalization Ratio was 13.54 % — a change of 2.02% (higher).

Debt/Market Cap

13.81 %

YoY

2.02%

Last updated:

Debt to Market Capitalization Ratio of Alcon is 2026 13.81 % . Debt to Market Capitalization Ratio of Alcon was 2025 13.54 % . It decreases by 2.02% higher compared to the previous year.

The Alcon Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2018
0.36 USD
Jan 1, 2019
10.03 USD
Jan 1, 2020
11.85 USD
Jan 1, 2021
11.80 USD
Jan 1, 2022
13.36 USD
Jan 1, 2023
13.53 USD
Jan 1, 2024
13.54 USD
Jan 1, 2025
13.81 USD
The Alcon Debt/Market Cap history
YEARDebt/Market CapYoY
13.81 %+2.02%
13.54 %+0.02%
13.53 %+1.32%
13.36 %+13.15%
11.80 %-0.38%
11.85 %+18.19%
10.03 %+2,697.06%
0.36 %-8.72%
0.39 %-6.46%
0.42 %-13.66%
0.49 %—
Access this data via the Eulerpool API

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcon stock

Debt to Market Capitalization Ratio of Alcon is 13.81 % in 2026.

Debt to Market Capitalization Ratio of Alcon changed from 13.54 % to 13.81 %, representing a 2.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Alcon since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Alcon with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Alcon

All Key Metrics — Alcon